Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. ViroGates A/S
  6. Company
    VIRO   DK0061030574

VIROGATES A/S

(VIRO)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
ViroGates A/S is a Denmark-based medical technology company. Its develops a product line suPARnostic, which measures the amount of amount of soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The plasma level of suPAR reflects immune activation and is increased in such infectious diseases as HIV-1-infection, malaria, tuberculosis, Streptococcus pneumonia bacteraemia, sepsis, pneumococcal pneumonia and bacterial and viral CNS infection. Also, high suPAR levels are associated with increased inflammation, disease progression and risk of mortality. Thus, measuring suPAR levels serves as a marker to determine chances for survival upon hospital admission, as well as for monitoring for prevention of disease progression and earlier intervention time point. suPARnostic has two versions: Quantitative Point of Care Quick Triage test, which serves for patient triage in acute care, and Quantitative ELISA Assay that aims at clinical routine use.

Number of employees : 14 people.
Sales per Business
20192020Delta
Prognostic3.58100%5.35100% +49.47%
DKK in Million
Sales per region
20192020Delta
Denmark3.58100%5.35100% +49.47%
DKK in Million
Managers
Name Title Age Since
Jakob Knudsen Chief Executive Officer 53 2011
Mark Christian Hvidberg da Silva Chief Financial Officer 31 2019
Jesper Eugen-Olsen, Dr. Chief Scientific Officer 58 2001
Thomas Krarup, Dr. Vice President-Global Sales & Marketing 58 2018
Kasper RogÚr Larsen Head-Marketing - -
May Britt Dyvelkov Vice President-Accounting 61 2019
Members of the board
Name Title Age Since
Lars Kongsbak, Dr. Chairman 60 2015
J÷rgen Axel Thorball, Dr. Director 59 2015
Lars Krogsgaard Non-Executive Director 54 2016
Henrik Stender, Dr. Director 56 2020
Shareholders
NameEquities%
Niels Peter Louis-Hansen 817,075 25.8%
Lars Krogsgaard 325,965 10.3%
Kim Erik Poul Ginnerup 325,965 10.3%
Jesper Eugen-Olsen 147,685 4.66%
J÷rgen Axel Thorball 10,204 0.32%
Jakob Knudsen 9,775 0.31%
Lars Kongsbak 6,968 0.22%
Thomas Krarup 4,977 0.16%
ViroGates A/S 2,585 0.082%
Mark Christian Hvidberg da Silva 0 -
Holdings
NameEquities%Valuation
VIROGATES A/S (VIRO) 2,585 0.082% 56,720 USD
Brand Portfolio
In partnership withAllbrands.markets
More brands of ViroGates A/S